View of CLINICAL, SUBCLINICAL CHARACTERISTICS AND RESULTS OF B-CELL NON-HODGKIN LYMPHOMA PATIENTS RECEIVING R-CHOP CHEMOTHERAPY REGIMEN AT CAN THO ONCOLOGY HOSPITAL IN 2021 – 2023

Return to Article Details CLINICAL, SUBCLINICAL CHARACTERISTICS AND RESULTS OF B-CELL NON-HODGKIN LYMPHOMA PATIENTS RECEIVING R-CHOP CHEMOTHERAPY REGIMEN AT CAN THO ONCOLOGY HOSPITAL IN 2021 – 2023 Download Download PDF